Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

Standard Dose
10MG;2MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is listed in Drugs@FDA under application 073007 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE Form and strength TABLET;ORAL - 10MG;2MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2025-06-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is listed in Drugs@FDA under application 073007 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE Form and strength TABLET;ORAL - 10MG;2MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2025-06-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE) | Drug Monograph | MedicHelpline